IQVIA Holdings | IQV - مصاريف البيع والإدارة





مصاريف البيع والإدارة تغيير تاريخ
Accenture USD 2.96B 6.78M 2026-03
Agilent USD 475M 10M 2026-06
Bruker USD 238.9M 3.2M 2026-06
Cardinal Health USD 1.62B 115M 2026-06
Celltrion KRW 9.32B 3.39B 2026-03
Charles River Laboratories USD 228.9M 69.47M 2026-06
Cigna USD 3.47B 152M 2026-06
Cognizant Technology Solutions USD 809M 18M 2026-06
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Danaher USD 2.07B 212M 2026-06
Dentsply International USD 364M 13M 2026-06
Deva Holding AS TRY 462.26M 48.18M 2023-09
Dianthus Therapeutics USD 12.47M 5.89M 2026-03
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Elevance Health USD 10.91B 309M 2025-12
Humana USD 3.36B 614M 2025-03
IBM USD 4.4B 1.42B 2026-03
Illumina USD 273M 1000K 2026-06
Infosys INR 7.53B 7.47B 2026-06
Kangmei Pharma CNY 237.06M 37.35M 2026-03
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Laboratory Of America USD 577.2M 26.2M 2026-06
Malin Corporation EUR 1.1M 400K 2024-12
McKesson USD 2.26B 468M 2026-06
Mettler Toledo International USD 263.33M 5.01M 2026-06
Organigram Holdings CAD 22.01M 14.28M 2026-03
Ovoca Bio EUR 617K 15K 2025-12
Pharma Mar EUR 17.12M 1.82M 2026-06
Qiagen NV USD 142.33M 60K 2026-06
Quest Diagnostics USD 529M 25M 2026-06
Revvity USD 278.58M 24.69M 2026-06
Sartorius EUR 221.3M 0 2026-06
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Thermo Fisher Scientific USD 1.91B 111M 2026-06
Tilray USD 24.85M 1.7M 2025-09
UnitedHealth USD 15.22B 1.44B 2025-09
Veeva Systems USD 138.88M 12.4M 2026-06
Veradigm USD 27.28M 5.24M 2022-12
Waters USD 405M 11M 2026-06
Zealand Pharma A/S 104M 12.19M 2026-03
Zz Pientze Pharmaceu CNY 223.14M 8.82M 2026-06